Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Bruchfeld

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Kidney International Reports|December 23, 2017
Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney DiseaseJoanna Gertow, Chang Zhi Ng, Rui Miguel Mamede Branca, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Rheumatology (Oxford, England)|March 4, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trialDuvuru Geetha, Christian Pagnoux, Sebastian E Sattui, et al.
Frontiers in Immunology|June 22, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitidesErik Hellbacher, Ann Knight, Peter Hemmingsson, et al.
Clinical Kidney Journal|January 12, 2026
The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working GroupEleni Frangou, Andreas Kronbichler, Stefanie Steiger, et al.
Clinical Kidney Journal|May 12, 2025
Malignancies and glomerulonephritis: when to suspect and when to screen?Ahmet Murt, Ilay Berke, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2019
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trialsCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patientsGaye Hafez, Jolanta Malyszko, Aleksandra Golenia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2025
Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)Y K Onno Teng, Eleni Frangou, Andreas Kronbichler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 13, 2019
ErratumCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Kidney International Reports|December 23, 2017
Altered Protein Composition of Subcutaneous Adipose Tissue in Chronic Kidney DiseaseJoanna Gertow, Chang Zhi Ng, Rui Miguel Mamede Branca, et al.
Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.
Rheumatology (Oxford, England)|March 4, 2025
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trialDuvuru Geetha, Christian Pagnoux, Sebastian E Sattui, et al.
Frontiers in Immunology|June 22, 2026
Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitidesErik Hellbacher, Ann Knight, Peter Hemmingsson, et al.
Clinical Kidney Journal|January 12, 2026
The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working GroupEleni Frangou, Andreas Kronbichler, Stefanie Steiger, et al.
Clinical Kidney Journal|May 12, 2025
Malignancies and glomerulonephritis: when to suspect and when to screen?Ahmet Murt, Ilay Berke, Annette Bruchfeld, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 2019
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trialsCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Clinical Kidney Journal|December 4, 2023
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patientsGaye Hafez, Jolanta Malyszko, Aleksandra Golenia, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2025
Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)Y K Onno Teng, Eleni Frangou, Andreas Kronbichler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 13, 2019
ErratumCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.
Pageof 16